| Presented by: | The American College of Allergy, Asthma & Immunology (ACAAI) |
| Lecturer | Bruce L. Zuraw, MD, William R. Lumry, MD and Michael M. Frank, MD |
| Approximate duration: | Not available |
| Summary points: | This audiovisual CME activity describes the prevalence, clinical characteristics, and presentation of hereditary angioedema and discusses the new therapies, their mechanisms of action, and the advantages and disadvantages of each. |
| Accreditation: | The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology designates this continuing medical educational activity for a maximum of 2 AMA PRA Category 1 Credit.
Expiration date: December 2009. |
| Other: | |
E-Mail this webcast/CME to a colleague
Advances in Hereditary Angioedema Treatment: Considerations, Criteria & the New Therapy Options for Treatment & Prevention of HAE Attacks
Go to webcast/CME
E-Mail this webcast/CME to a colleague
Remind me of this
